# Phase 6.5 Adversarial Review Summary

**Paper**: Phase Transition in ML Benchmark Concentration
**Date**: 2026-08-18
**Status**: COMPLETED
**Recommendation**: CONDITIONAL_ACCEPT

---

## Review Statistics

| Metric | R1 | R2 | Final |
|--------|----|----|-------|
| FATAL | 0 | 0 | 0 |
| MAJOR | 6 | 0 | 0 |
| MINOR | 5 | 3 | 8 |

## Convergence

- Rounds completed: 2 (R1, R2)
- Converged at: R2
- Criteria met:
  - FATAL issues: 0
  - MAJOR issues: 0
  - Persuasiveness: PASS

---

## R1 Issues (All Resolved)

### Accuracy Checker
1. **"+19% more" wording ambiguity** - Fixed to "+19 percentage points"
2. **h-m1 limitation not in Results** - Added footnote

### Bored Reviewer
3. **Missing practical example** - Added ImageNet vs MMLU example
4. **Related Work too brief** - Expanded to ~600 words

### Skeptical Expert
5. **Causal overclaim ("caused")** - Changed to "coincided with"/"associated with"
6. **Single baseline not acknowledged** - Added limitation

---

## Persuasiveness Assessment

| Check | Result |
|-------|--------|
| Abstract compelling | PASS |
| Problem clear in 1 min | PASS |
| Novelty clear in 2 min | PASS |
| Would continue reading | PASS |
| Attention lost at | Never |

---

## Numerical Verification

All 15 quantitative claims verified against source validation files:
- BIC improvement: 17.13
- Change points: April 2019, March 2021
- Emergent share shift: 7.53% → 26.54%
- Chi-square: 1025.23
- Traditional persistence: 47,068 papers, 11.7% share
- CV-NLP pre-2020 r: -0.131
- Pass rate: 83.3% (5/6)

---

## MINOR Issues for Human Review

See `065_human_review_notes.md` for 8 minor issues (typos, style, formatting) not auto-fixed.

---

## Final Outputs

- `06_paper_final.md` - Final reviewed paper
- `065_review_r1.md` - Round 1 adversarial review
- `065_review_r2.md` - Round 2 verification review
- `065_changelog.md` - Detailed change log
- `065_human_review_notes.md` - Minor issues for human review
